Page results
-
Once you have completed treatment for cancer at UCLH you will enter a period of follow-up care. Follow-up is an important way of monitoring your health.
-
Patient information for women who have chosen to have surgical management under general anaesthetic following a diagnosis of a miscarriage.
-
UCLH patient information for using Control IQ technology
-
The pelvic pain management service at UCLH was established in 2006 and our clinicians have a wealth of experience in managing women with abdominal and pelvic pain, and especially with those who have experienced complications following mesh implantation.
-
You can get your COVID-19 vaccine this weekend at venues across London
-
Our cancer team monitors all urgent, two-week wait, suspected cancer referrals from GPs. All appointments are carefully and systematically monitored to ensure a speedy and efficient patient journey from diagnosis to treatment or discharge.
-
This patient information aims to address the questions you may have about surgical management of endometriosis.
-
During your care at UCLH your clinician may order tests for you. We carry out thousands of different tests a year and know that waiting for results can be a difficult time.
-
Mr Seni Subair specialises in pregnancy and labour care, medical disorders (including perinatal mental health) in pregnancy,
-
Mr Ruwan Wimalasundera is a senior consultant obstetrician and fetal medicine specialist at UCLH. He manages all aspects of pregnancy, including both low -risk and high-risk pregnancies, especially older mothers and multiple pregnancies
File results
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment